Skip to main content

Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug

Abstract

The aim of the investigation was to prepare and characterize wheat germ agglutinin(WGA)-conjugated poly(d,l-lactic-co-glycolic) acid nanoparticles encapsulating mometasone furoate (MF) as a model drug and assess changes in its fate in terms of cellular interactions. MF loaded nanoparticles were prepared using emulsion–solvent evaporation technique. WGA-conjugation was done by carbodiimide coupling method. The nanoparticles were characterized for size, zeta potential, entrapment efficiency and in-vitro drug release. The intracellular uptake of nanoparticles, drug cellular levels, and anti-proliferative activity studies of wheat germ agglutinin-conjugated and unconjugated nanoparticles were assessed on alveolar epithelial (A549) cells to establish cellular interactions. Prepared nanoparticles were spherical with 10–15 μg/mg of WGA conjugated on nanoparticles. The size of nanoparticles increased after conjugation and drug entrapment and zeta potential reduced from 78 ± 5.5% to 60 ± 2.5% and −15.3 ± 1.9 to −2.59 ± 2.1 mV respectively after conjugation. From the cellular drug concentration–time plot, AUC was found to be 0.4745, 0.6791 and 1.24 for MF, MF-nanoparticles and wheat germ agglutinin-MF-nanoparticles respectively. The in-vitro antiproliferative activity was improved and prolonged significantly after wheat germ agglutinin-conjugation. The results conclusively demonstrate improved availability and efficacy of antiasthmatic drug in alveolar epithelial cell lines. Hence, a drug once formulated as mucoadhesive nanoparticles and incorporated in dry powder inhaler formulation may be used for targeting any segment of lungs for more improved therapeutic response in other lung disorders as well.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. H. Suh, B. Jeong, R. Rathi, and S. W. Kim. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly (ethylene oxide)-poly (lactide/glycolide) nanospheres. J. Biomed. Mater. Res. 42:331–338 (1998).

    Article  CAS  Google Scholar 

  2. J. M. Anderson, and M. S. Shive. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Delivery Rev. 28:5–24 (1997).

    Article  CAS  Google Scholar 

  3. J. Panyam, and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 553:(3)29–347 (2003).

    Article  CAS  Google Scholar 

  4. J. Panyam, W. Z. Zhou, S. Prabha, S. K. Sahoo, and V. Labhasetwar. Rapid endo-lysomal escape of poly (d,l-lactide-co-glycolide) nanoparticles: implication for drug and gene delivery. FASEB J. 16:1217–1226 (2002).

    Article  CAS  Google Scholar 

  5. I. J. Goldstein, and C. E. Hayes. The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem. 35:127–340 (1978).

    CAS  Article  Google Scholar 

  6. M. A. Clark, B. H. Hirst, and M. A. Jepson. Lectin-mediated mucosal delivery of drugs and microparticles. Adv. Drug Deliv. Rev. 43(2–3):207–223 (2000).

    Article  CAS  Google Scholar 

  7. R. Abu-Dahab, U. F. Schafer, and C. M. Lehr. Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion. Eur. J. Pharm. Sci. 14(1):37–46 (2001).

    Article  CAS  Google Scholar 

  8. C. M. Lehr. Lectin-mediated drug delivery: the second generation of bioadhesives. J. Control Release. 65(1–2):19–29 (2000).

    Article  CAS  Google Scholar 

  9. C. Crocker, Chang Yi Zhou, A. Bewtra, W. Kreutner, and R. Townley. Glucocorticosteroids inhibit leukotriene production. Ann. Allergy Asthma Immunol. 78:497–505 (1997).

    CAS  Article  Google Scholar 

  10. D. J. Margolskee. Clinical experience with MK-571: a potent and specific LTD4 receptor antagonist. Ann. N. Y. Acad. Sci. 629:148–156 (1991).

    Article  CAS  Google Scholar 

  11. N. Chanarin, and S. L. Johnston. Leukotrienes as a target in asthma therapy. Drugs. 47(1):12–24 (1994).

    CAS  Google Scholar 

  12. D. P. Skoner, L. Lee, W. J. Doyle et al. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann. Allergy. 65:206–210 (1990).

    CAS  Google Scholar 

  13. B. E. Barton, J. P. Jakway, S. R. Smith, and M. I. Siegel. Cytokine inhibition by a novel steroid, Mometasone furoate. Immunopharmacol. Immunotoxicol. 13(3):251–261 (1991).

    Article  CAS  Google Scholar 

  14. U. B. Kompella, N. Bandi, and S. P. Ayalasomayajula. Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Delivery Technology. 1:29–35 (2001).

    Google Scholar 

  15. Z. Grabarek, and J. Gergely. Zero-length cross-linking procedure with the use of active esters. Anal. Biochem. 185:131–135 (1990).

    Article  CAS  Google Scholar 

  16. S. Naazneen, S. Naik, T. Bagchi, and A. Misra. Assessment of in-vitro antiproliferative activity after intracellular drug delivery from wheat germ agglutinin-conjugated budesonide nanoparticles. J. Biomed. Nanotechnol. 3:61–67 (2007).

    Article  CAS  Google Scholar 

  17. M. Nikolova, I. Savova, and M. Marinov. An optimized method for investigation of the yeast viability by means of fluorescent microscopy. J. Cult. Collect. 3(1):66–71 (2002).

    Google Scholar 

  18. M. Wirth, A. Fuchs, M. Wolf, B. Ertl, and F. Gabor. Lectin mediated drug targeting: preparation, binding characteristics and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm. Res. 15:1031–1037 (1998).

    Article  CAS  Google Scholar 

  19. K. D. Wittrup, and J. E. Bailey. Comments on a segregated model of recombinant cultures. Biotechnol. Bioengineering. 35:525–532 (1990).

    Article  CAS  Google Scholar 

  20. J. A. Cidlowski, K. L. King, R. B. Evans-Storms, J. W. Montague, C. D. Bortner, and F. M. Hughes Jr. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog. Horm. Res. 51:457–490 (1996).

    CAS  Google Scholar 

Download references

Acknowledgments

The authors are thankful to the Department of Science and Technology, Government of India, for providing financial support under the Women Scientist Scheme (WOS-A).We also thank Technology Information and Forecasting Council’s (TIFAC) Centre of Relevance and Excellence in New Drug Delivery System.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Ambikanandan Misra.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Surti, N., Naik, S., Bagchi, T. et al. Intracellular Delivery of Nanoparticles of an Antiasthmatic Drug. AAPS PharmSciTech 9, 217–223 (2008). https://doi.org/10.1208/s12249-008-9036-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9036-x

Key words

  • intracellular levels
  • mometasone furoate
  • nanoparticles
  • poly(d
  • l-lactic-co-glycolic) acid
  • sustained delivery
  • wheat germ agglutinin